SAB Biotherapeutics

About:

SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.

Website: https://www.sab.bio

Twitter/X: SABBantibody

Top Investors: RA Capital Management, Merck, Marshall Wace, RTW Investments, National Institutes of Health

Description:

A biopharmaceutical development company leading the science and manufacturing of antibody therapeutics. Utilizing some of the most advanced antibody science in the world, SAB is delivering the world’s first large-scale platform to create immunoglobulins. This natural production platform holds the potential for treatment of public health problems, rare conditions, long-term diseases and global pandemic threats.